Combination Chemotherapy with Clostridium perfringens Phospholipase C and Cytosine Antimetabolites: Complementary Inhibition Directed at Membrane Lipids
Cancer Drug Delivery · 1983
DOI: 10.1089/cdd.1983.1.21 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Drug Delivery, 1983. Verfasst von M H Lee und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: NCI NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- NCI NIH HHS
Zitieren
APA
Lee, M. H., & Sartorelli, A. C. (1983). Combination Chemotherapy with Clostridium perfringens Phospholipase C and Cytosine Antimetabolites: Complementary Inhibition Directed at Membrane Lipids. Cancer Drug Delivery. https://doi.org/10.1089/cdd.1983.1.21
Vancouver
Lee MH, Sartorelli AC. Combination Chemotherapy with Clostridium perfringens Phospholipase C and Cytosine Antimetabolites: Complementary Inhibition Directed at Membrane Lipids. Cancer Drug Delivery. 1983. doi:10.1089/cdd.1983.1.21
BibTeX
@article{Lee1983,
author = {Lee, M H and Sartorelli, A C},
title = {Combination Chemotherapy with Clostridium perfringens Phospholipase C and Cytosine Antimetabolites: Complementary Inhibition Directed at Membrane Lipids},
journal = {Cancer Drug Delivery},
year = {1983},
doi = {10.1089/cdd.1983.1.21}
}
EUVIMED